Home / News / India /  Sputnik Light to be made in India soon: Russian foreign minister
Listen to this article

Talks to begin production of one-shot Covid-19 vaccine Sputnik Light in India are nearing completion, Russian news agency TASS quoted nagtion's External Affairs Minister Sergey Lavrov as saying on Monday.

Lavrov arrived in Delhi with Russian President Vladimir Putin and took part in the inaugural Indo-Russia '2+2' dialogue along with his Indian counterpart S Jaishankar. Indian Defence Minister Rajnath Singh and Russian Defence Minister Gen Sergey Shoigu also participated in the bilateral talks.

Earlier today, Russian Direct Investment Fund (RDIF), which helped create the Sputnik vaccines with the nation's Gamaleya Institute, said in a statement that it is actively cooperating with India’s regulatory authorities on registration of Sputnik Light as a standalone vaccine and a universal booster and expects it to be authorized in the country soon.

Sputnik Light is a one-shot vaccine based on human adenovirus serotype 26, the first component of the Sputnik V, which has already been approved for use in India.

“A major partner of RDIF, Dr. Reddy’s Laboratories, has conducted additional clinical trials of Sputnik Light in India. Positive data from these trials has also been presented to India's regulator," RDIF said.

The latest findings by the Gamaleya Center based on data from 28,000 subjects in Moscow have demonstrated that Sputnik Light administered standalone has 70 per cent efficacy against infection from the Delta variant of coronavirus during the first three months after vaccination.

The vaccine is 75 per cent effective among subjects under the age of 60. Efficacy of Sputnik Light as a booster against Delta variant for other vaccines will be close to the efficacy against the Delta variant of the Sputnik V vaccine: over 83 per cent against infection and over 94 per cent against hospitalisation.

RDIF claims that Sputnik Light has proven to be safe and highly effective by real-world vaccination data. In particular, the vaccine has demonstrated efficacy of between 78.6-83.7 per cent among the elderly as confirmed by the Ministry of Health of Buenos Aires, Argentina. Paraguay’s Ministry of Health also found Sputnik Light to be 93.5 per cent effective during the country’s ongoing vaccination campaign.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Edit Profile
Get alerts on WhatsApp
My ReadsRedeem a Gift CardLogout